Skip to content

17 May 2025

Huawei’s chip unit doubled revenue last year as firm gains China smartphone market share

Huawei’s chip unit doubled revenue last year as firm gains China smartphone market share

Revenue for HiSilicon, Huawei Technologies’ chip design unit, doubled last year owing to the telecoms equipment giant’s comeback in the high-end smartphone market, although its long-term growth still faces challenges, according to Counterpoint Research. HiSilicon’s “strong and loyal customer base in China” helped revenue jump 100 per cent in 2024, according to a report published […]

Huawei’s chip unit doubled revenue last year as firm gains China smartphone market share Read More »

DeepSeek paper offers new details on how it used 2,048 Nvidia chips to take on OpenAI

DeepSeek paper offers new details on how it used 2,048 Nvidia chips to take on OpenAI

Chinese artificial intelligence (AI) research lab DeepSeek has released a new research paper revealing in detail for the first time how it built one of the world’s most powerful open-source AI systems at a fraction of the cost of its competitors. “Insights into DeepSeek-V3: Scaling Challenges and Reflections on Hardware for AI Architectures”, co-authored by

DeepSeek paper offers new details on how it used 2,048 Nvidia chips to take on OpenAI Read More »

Nvidia CEO sees ‘no evidence’ of AI chip diversion into China

Nvidia CEO sees ‘no evidence’ of AI chip diversion into China

Nvidia chief executive officer Jensen Huang expressed confidence in his company’s trade partners and said there’s no evidence of its prized semiconductors being diverted to the Chinese market. Nvidia’s hardware is too large to be easily smuggled across borders and its customers are aware of the rules and self-monitoring, Huang told Bloomberg News in Taipei.

Nvidia CEO sees ‘no evidence’ of AI chip diversion into China Read More »

Biotech’s DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund

Biotech’s DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund

Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as the domestic biotechnology industry experiences its own “DeepSeek moment”, its founder said in an interview. ORI, established in 2015 with two funds that primarily invest in global biotech start-ups, is in the process of raising

Biotech’s DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund Read More »

Scroll to Top